AzTrials
AzTrials

ESWLESWLNCT06804928

Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During Extracorporeal Shock Wave Lithotripsy

A study testing Virtual Reality Glasses in people with ESWL and Anxiety, run by Akdeniz University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During ESWL Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
ESWL, Anxiety, Pain
What is being tested?
Virtual Reality Glasses
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Feb 2025to 1 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • being 18 years of age or older,
  • scheduled for elective ESWL due to renal or ureteral calculi,
  • being conscious and able to communicate,
  • voluntarily participated in the study after providing written informed consent,
  • absence of coagulopathy or bleeding disorders,
  • having a single radiopaque renal or ureteral calculus measuring ≤ 10 mm in diameter.

Who cannot join

  • visual or auditory impairments preventing the use of virtual reality glasses,
  • psychiatric or neurological disorders that could interfere with perception of the intervention,
  • a diagnosis of epilepsy,
  • the presence of multiple renal or ureteral calculi,
  • abdominal arterial aneurysm, urinary diversion or urinary obstruction,
  • the use of any sedatives or anxiolytics before or during the procedure.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Samsun Gazi State Hospital

    Samsun, Merkez, 55070

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Effect of Virtual Reality Glasses Used During Extracorporeal Shock Wave Lithotripsy (ESWL) on Patients' Pain, Anxiety, and Comfort Levels: A Randomized Controlled

Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During ESWL

Being tested
Virtual Reality Glasses
Medical subject headings
Anxiety Disorders, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality GlassesBehavioural

    Also called Control group

    During the procedure, the patient will wear virtual reality glasses and watch a video. The video will be played through the virtual reality glasses throughout the entire procedure.

Study groups in NCT06804928
Study groupRoleWhat they receive
VR-G (Virtual Reality Group) (1)ExperimentalDuring the procedure, the patient will wear virtual reality glasses and watch a video. The video will be played through the virtual reality glasses throughout the entire procedure.
Receives: Behavioral: Virtual Reality Glasses
Control Group (2)No interventionNo intervention will be applied to the patients in the control group, and the standard care protocol of the clinic will be followed.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VAS

    Pain levels will be assessed.

    Measured: Data will be collected 10 minutes before the procedure.

  2. Visual Anxiety Scale (VAS-A)

    Anxiety levels will be assessed.

    Measured: Data will be collected 10 minutes before the procedure.

  3. Visual Comfort Scale

    Comfort levels will be assessed.

    Measured: Data will be collected 10 minutes before the procedure.

  4. Spielberger Trait Anxiety Inventory (STAI-II)

    It will be used to measure trait anxiety levels before the procedure.

    Measured: The measurement will be conducted only once, 10 minutes before the procedure.

  5. VAS

    Pain levels will be assessed.

    Measured: Data will be collected 30 minutes after the procedure.

  6. Visual Anxiety Scale (VAS-A)

    Anxiety levels will be assessed.

    Measured: Data will be collected 30 minutes after the procedure.

  7. Visual Comfort Scale

    Comfort levels will be assessed.

    Measured: Data will be collected 30 minutes after the procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2025
  2. Study start1 Feb 2025
  3. Primary completion1 Sep 2025
  4. Study completion1 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06804928
Sponsor's protocol ID
Scansuscansu92
Acronym
ESWL
Status last verified
Nov 2025
First submitted
28 Jan 2025
Last updated
18 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Glasses in people with ESWL and Anxiety, run by Akdeniz University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VAS (time frame: Data will be collected 10 minutes before the procedure.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in